Avrupa ülkelerinde akılcı ilaç kullanımı ve akılcı reçete yazılımı konusunda en büyük düşünce grubu olan Piperska grubu 17-19 Şubat 2010 da berlinde toplandı. Toplantıda Avrupadaki geri ödeme problemlerinin tartışılması yanında özellikle "yetim ilaçlar" ve kanser ilaçlarının durumu tartışıldı. Birçok Avrupa ülkesinin geri ödeme kurumlarının başkan veya yöneticilerinin katıldığı bu toplantıda Prof. Dr. F. Cankat Tulunay Piperska grubu daimi üyesi olarak seçildi. Grup hakkında daha fazla bilgi: http://www.piperskagroup.com/ adresinden elde edilebilir. Berlin toplantısı programı:

Piperska Meeting Berlin February 2010 (17 to 19 February 2010)

Conference venue – AOK facilities in Berlin

I) 17 February 2010

• Informal meal and discussions in the evening

II) 18 February 2010

General meeting theme – Improving the rational introduction of new medicines

Joint Chairpeople – Gisbert Selke and Lars Gustafsson

A) Introduction and feedback

9.00 – 9.15 Welcome, Objectives and Aims for the next two days
Lars, Silvio and Gisbert

9.15 – 9.30 Introduction new members
Lars, Silvio and Gisbert

9.30 – 10.45 Feedback on activities during 2009
i) Glasgow course – Presentation and discussion led by Ken Paterson
a) Evaluation of the course (participant feedback, etc.)
b) Piperska Web page/ content including a message board
c) Future courses – similar and/ or advanced course including issues such as forecasting, critical drug evaluations and reimbursement decision making
ii) Cross national comparison studies – Presentation and discussion led by Brian Godman
Key findings and next steps
iii) Update on ‘Risk sharing paper’ and next steps (if pertinent) – Discussion led by Brian Godman

10.45 – 11.15 Coffee

11.15 – 12.00 iv) eSPC project – brief update by Lars
v) Country feedback – Discussions led by Gisbert and Irene
Activities and developments during the year under the Piperska banner

B) Piperska mission/ vision

12.00 – 13.15 Piperska mission/ vision – Led by Silvio, Lars and Brian
a) Aims, structure, where Piperska fits in with other organisations, future membership, and ways forward including future funding possibilities
b) Discussion of circulated draft documents and suggested amendments/ additions in small groups, feedback and consolidation
c) Subsequent refinement of agreed mission/vision, aims and structure (led by Brian)

13.15 – 14.15 Lunch

C) Orphan drugs – next steps in Pan-European project

14.15 – 17.30 Aims, objectives, next steps - discussions led by Björn, Mahan and Roberta

Group working including aims, objectives, current status and next steps

Agreed action plan

Participating countries will be encouraged to bring data/ ideas based on a pre-circulated draft protocol

D) Potential joint alliance between Piperska and European Cancer Initiative (OECI) to enhance the rational introduction of new cancer medicines including future personalised approaches

14.15 - 14.30 Introduction and objectives including the objectives for the smaller group discussions during the workshop session - Lars and Ulrik
14.30-14.45 Rationale behind the initiative given increasing scarce resources - Alan
14.45 – 15.00 Initiative outline/ rationale - Piperska perspective - Ken (building on pre-circulated documents)
15.00 - 15.20 Similarly from the European Cancer Centres - Ulrik (again building on pre-circulated documents)
15.20 – 17.00 Break into smaller groups to progress the joint venture and its focus including future action plans
17.00 – 17.45 Feedback from group sessions - Ken and Nils/ other attendees from Cancer Centres
17.45 -18.00 Conclusions and next steps - Lars and Ulrik

Break during the afternoon

17.30/18.00 Close Day 1

19.00 to late Conference dinner
Venue (to be added)

III) 19 February 2010

9.00 – 9.15 Summary Day 1 - Discussions led by Silvio and Lars

E) Rational Introduction of new medicines

9.15 – 12.15 Models for the rational introduction of new medicines – Presentation and discussions led by Björn, Brian, Lars, Oyvind, Rikard, Ulrich and Anna
a) Circulated draft paper – aims, critique and suggested journal(s)
b) Planned paper for GGW – Germany via Gisbert) – aims and next steps (scheduled for finalisation in April 2010 and publication in May 2010)
c) Presentation on PHIS (hospital pharmaceutical market) including aims and objectives of the project and key findings – Sabine Vogler (OBIG)
d) Workshop with University hospitals in Europe on the ‘Rational Introduction of New Medicines’ – Presentation of proposals by Oyvind Melien and Rikard Malmstrom. Group working on feasibility, likely participants, tentative programme, likely costs/ funding, timing and broadcasting
e) Potential expansion of PHIS project for selected biological drugs including biosimilars – aims, protocol and next steps. Discussions led by Ulrich and Anna (potential activities will be circulated beforehand)

Break during the discussions (10.45 – 11.15)

E) Summary and close

12.15 – 13.00 Summary and next steps including future funding sources - Discussions led by Silvio, Lars and Gisbert

13.00 Lunch and close